Why Shares of Soleno Therapeutics Are Booming on Tuesday

Why Shares of Soleno Therapeutics Are Booming on Tuesday

Source: 
Motley Fool
snippet: 
  • Soleno specializes in treating rare metabolic disorders.
  • The company's lead therapy, DCCR, fared well as a treatment for Prader-Willi syndrome.
  • The company could use the news to raise more funds.